D
Olema Pharmaceuticals, Inc. OLMA
$5.59 -$0.17-2.95% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -10.38% -4.65% -19.39% 13.01% 22.40%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 12.93% 18.86% 10.69% 61.17% 55.22%
Operating Income -12.93% -18.86% -10.69% -61.17% -55.22%
Income Before Tax -44.11% 1.88% -25.38% -60.71% -51.19%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -44.11% 1.88% -25.38% -60.71% -51.19%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -44.11% 1.88% -25.38% -60.71% -51.19%
EBIT -12.93% -18.86% -10.69% -61.17% -55.22%
EBITDA -12.85% -18.78% -10.64% -61.39% -55.50%
EPS Basic 5.13% 36.17% -4.40% -26.21% -9.38%
Normalized Basic EPS 26.79% 23.90% 5.48% -26.24% -9.40%
EPS Diluted 5.13% 36.17% -4.40% -26.21% -9.38%
Normalized Diluted EPS 26.79% 23.90% 5.48% -26.24% -9.40%
Average Basic Shares Outstanding 51.91% 53.72% 20.10% 27.32% 38.22%
Average Diluted Shares Outstanding 51.91% 53.72% 20.10% 27.32% 38.22%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --